NIH-funded research NIH-funded research

Nutrient clues to tackle stubborn bacterial infections

Official title: Nutrient-driven bacterial physiology in recalcitrant infections.

Funded at University of Oregon · NIH-11357587 · Data updated 2026-11-12

This project studies how the nutrients in the human body shape stubborn bacteria so we can find better ways to treat chronic infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Oregon
NIH-funded
Lab location1 site (Eugene, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$368,774
NIH project number5R35GM155575-03
Project IDNIH-11357587 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with chronic infections where GPAC bacteria are suspected or identified, especially in situations involving anaerobic, hard-to-treat infections.

Less likely to help

Patients with infections caused by bacteria outside this focus or those not experiencing chronic, biofilm-associated infections may not directly benefit.

What this research studies

Chronic infections are hard to treat because bacteria slow down and form protective biofilms, making standard antibiotics less effective. The research focuses on how the body's nutrient environment pushes bacteria into these tough states and how bacterial metabolism responds. By studying gram-positive anaerobic cocci, the team hopes to uncover new ways to bypass antibiotic tolerance and disrupt biofilms. The work builds on early findings that nutrient availability strongly influences bacterial behavior in chronic infections. If successful, this could reveal new targets to improve healing and reduce recurrent infections.

Why it matters

Potential benefit: If successful, patients with chronic infections could have more effective treatments that overcome antibiotic tolerance and biofilm-related persistence.

How similar studies have gone: Previous work suggests nutrients can regulate bacterial behavior and biofilm formation, supporting a potentially fruitful direction, though specifics for GPAC are still emerging.

Where this research is happening

  • University of Oregon
    Eugene, United States
    Active

Researchers

  • Principal investigator: Spero, Melanie a. — University of Oregon
  • Study coordinator: Spero, Melanie a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.